Skip to main content
    • Aa
    • Aa

Multihospital Outbreak of Clostridium difficile Ribotype 027 Infection: Epidemiology and Analysis of Control Measures

  • Mamoon A. Aldeyab (a1), Michael J. Devine (a2), Peter Flanagan (a3), Michael Mannion (a3), Avril Craig (a2), Michael G. Scott (a3), Stephan Harbarth (a4), Nathalie Vernaz (a5), Elizabeth Davies (a3), Jon S. Brazier (a6), Brian Smyth (a7), James C. McElnay (a1), Brendan F. Gilmore (a8), Geraldine Conlon (a3), Fidelma A. Magee (a3), Feras W. Darwish Elhajji (a1), Shaunagh Small (a3), Collette Edwards (a3), Chris Funston (a3) and Mary P. Kearney (a3)...

To report a large outbreak of Clostridium difficile infection (CDI; ribotype 027) between June 2007 and August 2008, describe infection control measures, and evaluate the impact of restricting the use of fluoroquinolones in controlling the outbreak.


Outbreak investigation in 3 acute care hospitals of the Northern Health and Social Care Trust in Northern Ireland.


Implementation of a series of CDI control measures that targeted high-risk antibiotic agents (ie, restriction of fluoroquinolones), infection control practices, and environmental hygiene.


A total of 318 cases of CDI were identified during the outbreak, which was the result of the interaction between C. difficile ribotype 027 being introduced into the affected hospitals for the first time and other predisposing risk factors (ranging from host factors to suboptimal compliance with antibiotic guidelines and infection control policies). The 30-day all-cause mortality rate was 24.5%; however, CDI was the attributable cause of death for only 2.5% of the infected patients. Time series analysis showed that restricting the use of fluoroquinolones was associated with a significant reduction in the incidence of CDI (coefficient, —0.054; lag time, 4 months; P = .003).


These findings provide additional evidence to support the value of antimicrobial stewardship as an essential element of multifaceted interventions to control CDI outbreaks. The present CDI outbreak was ended following the implementation of an action plan improving communication, antibiotic stewardship, infection control practices, environmental hygiene, and surveillance.

Corresponding author
Clinical and Practice Research Group, School of Pharmacy, Queen's University Belfast, Belfast BT9 7BL, United Kingdom (
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1. I Thompson . Clostridium difficile-associated disease: update and focus on non-antibiotic strategies. Age Ageing 2008;37:1418.

3. LV McFarland . Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol 2008;5:4048.

4. A-C Labbé , L Poirier , D MacCannell , et al.Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother 2008;52:31803187.

5. M Warny , J Pepin , A Fang , et al.Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366:10791084.

6. SB Debast , N Vaessen , A Choudry , EA Wiegers-Ligtvoet , RJ van den Berg , EJ Kuijper . Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors. Clin Microbiol Infect 2009;15:427434.

7. DR MacCannell , TJ Louie , DB Gregson , et al.Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from eastern and western Canada. J Clin Microbiol 2006;44:21472152.

9. MA Aldeyab , DL Monnet , JM López-Lozano , et al.Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother 2008;62:593600.

11. MA Aldeyab , S Harbarth , N Vernaz , et al.Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients. Antimicrob Agents Chemother 2009;53:20822088.

12. GL O'Neill , FT Ogunsola , JS Brazier , BI Duerden . Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile. Anaerobe 1996;2:205209.

14. SJ Lewis , KW Heaton . Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997;32:920924.

19. U Helfenstein . Box-Jenkins modelling in medical research. Stat Methods Med Res 1996;5:322.

21. SP Stone , BS Cooper , CC Kibbler , et al.The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis 2007;7:282288.

22. MJ Schwaber , A Simhon , C Block , V Rovai , N Ferderber , M Shapiro . Factors associated with nosocomial diarrhea and Clostridium difficile-associated disease on the adult wards of an urban tertiary care hospital. Eur J Clin Microbiol Infect Dis 2000;19:915.

25. RC Owens Jr, CJ Donskey , RP Gaynes , VG Loo , CA Muto . Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008;46(suppl 1):S19S31.

27. RM Cadle , MD Mansouri , N Logan , DR Kudva , DM Musher . Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis. Am J Health Syst Pharm 2007;64:23592363.

28. S Dial , JA Delaney , AN Barkun , S Suissa . Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005;294:29892995.

29. A Apisarnthanarak , JE Zack , JL Mayfield , et al.Effectiveness of environmental and infection control programs to reduce transmission of Clostridium difficile. Clin Infect Dis 2004;39:601602.

32. EJ Kuijper , B Coignard , P Tüll , ESCMID Study Group for Clostridium difficile, EU Member States, European Centre for Disease Prevention and Control. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006;12(suppl 6):218.

33. OW Morgan , B Rodrigues , T Elston , et al.Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS one 2008;3(3):e1812.

34. VG Loo , L Poirier , MA Miller , et al.A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:24422449.

35. B Hubert , VG Loo , A-M Bourgault , et al.A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec. Clin Infect Dis 2007;44:238244.

37. A Goorhuis , T Van der Kooi , N Vaessen , et al.Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis 2007;45:695703.

38. M Miller , D Gravel , M Mulvey , et al.Health care-associated Clostridium diffidi infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010;50:194201.

40. JC McElnay , MG Scott , JY Sidara , P Kearney . Audit of antibiotic usage in medium-sized general hospital over an 11-year period: the impact of antibiotic policies. Pharm World Sci 1995;17:207213.

41. FA Al-Eidan , JC McElnay , MG Scott , MP Kearney . Clostridium difficile-associated diarrhoea in hospitalised patients. J Clin Pharm Ther 2000;25:101109.

42. L Valiquette , B Cossette , Garant M-P, H Diab , J Pépin . Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007;45(suppl 2):S112S121.

43. RP Vonberg , EJ Kuijper , MH Wilcox , et al.Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect 2008;14(suppl 5):220.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 10 *
Loading metrics...

Abstract views

Total abstract views: 203 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 24th June 2017. This data will be updated every 24 hours.